References
- Palferman T G, Webley M. A comparative study of nabumetone and indomethacin in ankylosing spondylitis. Eur J Rheumatol Inflamm 1991; 11: 23–9
- Melarange R, Blower P, Spangler R. Comparison of the anti-inflammatory activity and gastrointestinal irritancy of nabumetone, ibuprofen, and diclofenac in rats following chronic administration. Eur J Rheumatol Inflamm 1994; 14: 23–7
- Roth S H. From peptic ulcer disease to NSAID gastropathy. An evolving nosology. Drugs Aging 1995; 6: 358–367
- Nyman J, Larsson H, Wallentin L. Research group on instability in coronary artery disease in southeast Sweden. Prevention of serious cardiac events by 10s-dose aspirin in patients with silent myo-cardial ischaemia. Lancet 1992; 3409: 497–501
- Antiplatelet Trialists's Collaboration. Collaborative overview of randomised trials of antiplatelet Therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81–106
- Freed M I, Audet P R, Zariffa N, Krishna G G, Ikon B E, Everitt D E, Brown L E, Rizzo S M, Nichols A I, Jorkasky D K. Comparative effects of nabumetone, sulindac, and indomethacin on urinary prostaglandin excretion and platelet function in volunteers. J Clin Pharmacol 1994; 34: 1098–108
- Cipollone F, Ganci A, Panara M R, Greco A, Cuccurullo F, Patrono C, Patrignani P. Effects of nabumetone on prostanoid biosynthesis in humans. Clin Parmacol Ther 1995; 58: 335–41
- Alshameeri R S, Mammen E F. Clinical experience with the Thrombostat 4000. Semin Thromb Haemost 1995; 21(suppl. 2)1–10
- Kratzer M AA, Born G VR. Simulation of primary haemostasis. in vitro. Haemostasis 1985; 15: 357–62
- Kretschmer V, Schiber B, Sohngen D, Dietrich G. In vitro bleeding test – a simple method for the detection of aspirin effects on platelet function. Thromb Haemost 1989; 56: 593–602
- Ulshofer B, Dorst V, Kretschrner V, Kohl H, Riedmiller H. Hemostaseological management of urological operations in patients taking aspirin using the Thrombostat 4000. Semin Thromb Hemost 1995; 21(suppl. 2)52–8
- Beck K H, Mohr P, Bleckmann U, Schweer H, Kretschmer V. Desmopressin effect on acetylsalicylic acid impaired platelet function. Semin Thromb Hemost 1995; 21(suppl. 2)32–9
- Abrams C S, Ellison N, Budzynski A Z, Shattil S J. Direct detection of activated platelets and platelet-drived microparticles in humans. Blood 1990; 75: 128–38
- Lindahl T L, Festin R, Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: An improved method for detection of platelet activation. Thromb Haemost 1992; 68: 221–5
- Coller B S, Anderson K, Weisman H F. New antiplatelet agents: Platelet GPIIb/IIIa antagonists. Thromb Haemost 1995; 74: 302–8
- Colton T. Statistics in Medicine. Little & Brown, Boston 1974
- Ivy A C, Shapiro P F, Melnick P. The bleeding tendency in jaundice. Surg Gynecol Obster 1935; 60: 781, (Abstr.).
- Lind S E. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547–52
- Topol E J, Plow E F. Clinical trials of platelet receptor inhibitors. Thromb Haemost 1993; 70: 94–8
- Larsson A, Bålöw R M, Lindahl T L, Forsberg P O. Chicken IgG: utilizing the evolutionary advantage. Poultry Sci 1993; 27: 456–63
- Dahl S L. Nabumetone: a ‘nonacidic’ nonsteroidal antiinflammatory drug. Ann Pharmacother 1993; 21: 456–63
- Larsson A, Lindahl T L. Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist. Uppsala J Med Sci 1994; 99: 121–30